Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study

INTRODUCTION: Activated Protein C [APC] improves outcome in immunocompetent patients with severe sepsis particularly in those who are perceived to have high mortality risk. Before embarking on a trial of APC administration in immunocompromised septic patients, a preliminary study on plasma levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Panwar, Rakshit, Venkatesh, Bala, Kruger, Peter, Bird, Robert, Gill, Devinder, Nunnink, Leo, Dimeski, Goce
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772189/
https://www.ncbi.nlm.nih.gov/pubmed/19840396
http://dx.doi.org/10.1186/1756-8722-2-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772189/
https://www.ncbi.nlm.nih.gov/pubmed/19840396
http://dx.doi.org/10.1186/1756-8722-2-43

Ejemplares similares